Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

1. Ponz-Sarvisé, M.
2. Nguewa, P.A.
3. Pajares, M.J.
4. Agorreta, J.
5. Lozano, M.D.
6. Redrado, M.
7. Pio, R.
8. Behrens, C.
9. Wistuba, I.I.
10. García-Franco, C.E.
11. García-Foncillas, J.
12. Montuenga, L.M.
13. Calvo, A.
14. Gil-Bazo, I.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/1078-0432.CCR-10-3381 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus